myrtecaine

This page covers all myrtecaine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium voltage-gated channel subfamily H member 2.

Targets

Potassium voltage-gated channel subfamily H member 2

Phase 2 pipeline (1)

• Nopoxamine · Cardiovascular
  Nopoxamine works by blocking potassium channels in the heart to help stabilize heart rhythm.

Patent intelligence

• myrtecaine patent landscape — aggregated cliff calendar, attackable patents, originator estates